Onconetix IncONCO
Price$0.74

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $645.8K-74.4% YoYTTM through 30 Jun 2026
Net Income -$10.2MTTM through 30 Jun 2026
Free Cash Flow -$10.3MTTM through 30 Jun 2026

Margins

Current
Gross Margin-7.7%
Operating Margin-47,657.2%
Net Margin-1,578.8%

Returns

-123.3%ROE
-25.2%ROA

Balance Sheet Health

Debt / Equity0.02x
Current Ratio1.41x
Net Debt-$3.4Mnet cash position
Cash & Equivalents$5.9M

Quality Metrics

Altman Z-Score-14.16
Piotroski F-Score3 / 9
FCF Margin-1,600.5%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'23'24'25
FY2025: $815.4K
Diluted EPS
'21'22'23'24'25
FY2025: $-14.96

Dividend

No dividend

Capital Allocation

Capex Intensity4.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.